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Abstract
Background: Malnutrition is a well-known complication in cystic fibrosis (CF). There is good evidence that
maintaining a normal body-weight correlates well with improved survival in CF. Energy intake in excess of
120% of the estimated average requirement (EAR) has been advised since 1980s.
Objectives: To investigate the nutritional intake and status in the adult Scandinavian CF-population.
Subjects/Methods: A cross-sectional multi-centre study was used to investigate the nutritional status of 456
adult CF-patients (20032006). Height and weight were measured and body mass index (BMI) and z-scores
were calculated. Pulmonary function was examined by dynamic spirometry. A 7-day pre-coded food record
(FR) obtained energy and nutrient intake data in 180 patients.
Results: The mean energy intake was 114 (SD 30.0)% of EAR and thus significantly lower than the target of
120% EAR (pB0.001) for patients with pancreatic insufficiency (PI) (n136). Mean BMI was 22.0 (SD 2.9),
the prevalence of BMI B18 was 13% and the prevalence of BMI ]25 was 15% (n136). Mean BMI was
20.8 (SD 2.4) in PI-patients with FEV1B70% and 23.2% (SD 3.0), in PI-patients with FEV1 ]70%, mean
difference 2.4, (95% CI: 1.5, 3.3) (pB0.001), but there was no difference in energy intake. BMI ]18.5 and a
reported energy intake B120% were revealed in 54% of the PI-patients.
Conclusions: The energy intake did not reach the recommended 120% EAR, but the prevalence of
underweight was lower than reported in other studies. The recommendation may exceed the requirement
for a number of CF-patients. The nutritional status must still be closely monitored and nutritional advice and
intervention should be individualised and adjusted to actual needs.
Keywords: cystic ﬁbrosis; adult; body mass index; energy intake; nutritional requirement; forced expiratory volume
Received: 28 June 2011; Revised: 7 September 2011; Accepted: 13 October 2011; Published: 17 November 2011
C
ystic fibrosis (CF) is an autosomal recessive
genetic life-shortening disorder. Survival has
improved over time. A UK model predicts an estimated
median survival of 50 years for a child born with CF in
2000 or later (1). In 2002, predicted survival at age 25
years was 95% for Swedish patients born in 1991 or later
(2). The mean incidence of CF in Sweden is calculated to
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(3). The incidence in Norway is not known.
CF is characterised by multi-organ involvement pri-
marily affecting the lungs and the digestive tract (4).
Approximately 85% of patients with CF have pancreatic
insufficiency (PI) leading to maldigestion and malabsorp-
tion (4, 5). Fat absorption between 85 and 95% of intake
should be achievable with present enzyme preparations,
but a substantial number of patients may not achieve this
level of absorption (5).
Respiratory exacerbations and declining pulmonary
function are major factors associated with increased
resting energy expenditure (REE) in CF-patients (4, 69).
The relationship between REE and pulmonary function
suggests that an increase in REE occurs when forced
expiratory volume in one second (FEV1) falls below 70%
predicted value (6). The American CF Adult Care Con-
sensus defines FEV1 ]70% of predicted value as normal
ormildlungdysfunction(10).Additionalfindingssupport
the notion that genotype and PI may be determinants of
REE (7, 11, 12).
CF-related diabetes (CFRD) has been shown to
worsen pulmonary function and nutritional status (13),
although new data showed no difference in BMI between
patients with and without CFRD (14).
The loss of nutrients and energy, and the increased
REE result in higher nutritional needs. Accordingly,
malnutrition is a well-known complication in subjects
with CF leading to low weight, stunting, osteoporosis,
essential fatty acid deficiency and low serum levels of the
fat-soluble vitamins (4, 15, 16). The importance of
nutritional status for survival of CF-patients is well
documented and nutritional support is one of the
cornerstones in the treatment of CF (7, 15, 1719).
In a European consensus report, malnutrition is
defined as body mass index (BMI) below 18.5 in adults
 18 years of age (4). The American CF Adult Care
Consensus defines malnutrition as BMI B19 (10). The
Cystic Fibrosis Foundation recommends maintaining
BMI ]22 in females and BMI ]23 in males aged 20
years and older, respectively (20).
Although malnutrition has been the main cause for
nutritional concern in CF, overweight also exists. The
prevalence of overweight and obesity (BMI  25) in
adults with CF homozygous for the deltaF508 mutation
was 10% based on data from the UKCF database in 2002
(21). As survival in CF increases, the potential risk of
high BMI in adults may need concern.
Energy intake in excess of 120% estimated average
requirement, (EAR) for energy has been advised for CF-
patients (4, 7, 22). To achieve this level of energy intake, a
high-fat diet is commonly advised (4, 15), usually more
than 35% of energy (E%) from fat (7, 10).
Most reports of dietary intake in CF-patients focus on
children, although there are a few reports focusing on
energy and nutrient intakes in adults (2326).
Aim of the study
We investigated the energy intake and nutritional status,
indicated by BMI, in the adult Scandinavian CF-popula-
tion, with emphasis on PI patients.
We also investigated if PI-patients reached the recom-
mended energy intake for CF of 120%150% EAR of
Nordic Nutrition Recommendations (NNR) (27).
Furthermore, we wanted to find out if there were
differences in the energy intake between PI- and PS-
patients, between patients with normal and decreased
lung function and between patients with and without
CFRD.
Materials and methods
Study population
This was a cross-sectional, multi-centre study, initiated
and designed by the Scandinavian Cystic Fibrosis Study
Consortium (SCFSC), investigating the nutritional status
of the CF patients in Denmark, Norway and Sweden.
The Regional Ethics Committees in each country
approved the study, and informed written consent was
obtained from all patients.
Patients were included consecutively from September
2003 to May 2006, when in clinically stable condition.
Inclusion criteria were adults (]18 years of age) with
confirmed CF diagnosis based on clinical features,
repeatedly (] two) positive sweat tests (chloride, Cl
>60 mmole/l) and/or the presence of a known disease-
causing mutation on each CFTR gene. Pregnancy was the
only exclusion criterion.
Patients using pancreatic enzymes were defined as
pancreatic insufficient. Patients using insulin or oral
anti-diabetics were defined as having CFRD (14). Pul-
monary function was examined at inclusion by dynamic
spirometry at each centre. From measured forced vital
capacity and expiratory volume in 1 second (FEV1)i n
litres, percentage of predicted values was calculated using
Solymar and Quanjer reference equations for patients
B19 and ]19 years, respectively (28, 29). FEV1  70%
predicted was defined as normal or mild lung dysfunction
(10). Weight was measured in the morning wearing
undergarments. Height was measured with no stockings
or shoes and the means of three measurements were
recorded. BMI was calculated. For calculation of BMI
z-score, the reference values of Nysom were used (30).
Seven of the eight CF-centres in Denmark, Norway
and Sweden participated with a total of 456 patients ]18
years (Denmark 131 patients, Norway 83 patients,
Sweden 242 patients). Food recording (FR) was done in
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burg due to lack of resources. Demographic data exist for
all the 456 patients and nutritional data exist for 180
patients (40%). The percentage of patients completing
FRvaried between the centres (Copenhagen 21%, Bergen
54%, Oslo 70%, Lund 59%, Stockholm 67% and Uppsala
14%).
Patients post-lung transplant (n30) were excluded
from the calculations in this article.
Of the remaining 426 patients, 347 patients were
pancreatic insufficient (136 patients with FR) and 79
patients were pancreatic sufficient (38 patients with food
records, FR).
Assessment of dietary intake
A 7-day FR obtained energy and nutrient intake data.
Nationally designed pre-coded forms were used, together
with household measures and photographs to describe
food portions sizes to assess the entire diet over 7 days.
Seven days were chosen to eliminate bias related to
different intake on weekdays and weekends. The Swedish
and Danish pre-coded forms are validated (31, 32),
whereas the validation of the Norwegian form has not
yet been published. A CF dietitian instructed the patients
how to complete the FR. The records were coded and
analysed for energy and nutrients. In Sweden, this was
done at the National Food Administration using the
software MATs (Rudans La ¨ttdata) with the database PC-
Kost, in Denmark at Danish National Food Institute
using the GIES software and in Norway at the Depart-
ment of Nutrition, University of Oslo, using the KBS
software. The calculation of energy was standardised
using the factor 17 kJ for protein and carbohydrate
(exclusive fibre) and 37 kJ for fat.
The reported energy and nutrient intake is the sum of
food intake and oral- enteral energy supplements. Intake
of vitamins, minerals and trace elements from supple-
mentation was collected, and will be reported separately.
The energy intake as a percentage of EAR was
calculated using reference values for weight and physical
activity level (PAL: total energy expenditure divided by
basal metabolism). PAL equal to 1.6, corresponding to
sedentary work and limited physical activity in leisure
time, was used (27).
Statistics
Continuous variables are described by means and stan-
dard deviations (SD) and categorical variables by counts
(per cent). The one- and two-sample t-test and one-way
ANOVA were used to compare continuous variables. The
distributions of the continuous variables were determined
to be sufficiently normal for the parametric tests to be
appropriate (33). To compare categorical variables, 22
tables were formed for each comparison. All the expected
counts were above five and Pearson’s chi-squared test was
used in all cases. Statistical significance was set at pB
0.05. The analyses were performed using SPSS version 16.
Results
Patients with pancreatic insufficiency (PI)
Data for 347 PI-patients are shown in Table 1. Patients
completing FR, 136/347 (39%), were 2.8 years older and
had a higher BMI than the patients not completing the
FR. Both groups had normal BMI, and BMI z-score and
lung function did not differ between the groups.
Table 1. Demographic and clinical data for 347 adult patients with cystic ﬁbrosis and pancreatic insufﬁciency
All patients n347 Mean (SD) FR n136 Mean (SD) No FR n211 Mean (SD) p-values
Age, years 29.6 (8.5) 31.3 (9.8)
a 28.5 (7.3)
a 0.005
FEV1, % predicted 68.0 (25.3) 69.4 (26.3) 67.2 (24.6) 0.43
FVC, % predicted 87.0 (21.9) 87.0 (22.4) 87.0 (21.6) 0.98
BMI, kg/m
2 21.6 (2.9) 22.0 (2.9)
b 21.4 (2.9)
b 0.042
BMI z-score 0.51 (1.1) 0.39 (1.1) 0.59 (1.2) 0.10
N (%) N (%) N (%)
Female 152 (44) 67 (49) 85 (40) 0.10
Diabetes mellitus (DM) 60 (17) 28 (21) 32 (15) 0.19
FEV1B70% of expected 178 (52) 67 (50) 111 (53) 0.54
BMI B19.0 62 (18) 22 (16) 40 (19) 0.51
BMI B18.5 44 (13) 17 (13) 27 (13) 0.94
BMI]25.0 39 (11) 20 (15) 19 (9) 0.10
Note: FR: food records.
aAge difference: 2.8, 95% CI (0.88, 4.7).
bBMI difference: 0.6, 95% CI (0.024, 1.3).
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(18.524.9), 13% were underweight and 15% were over-
weight or obese.
BMI]22 was achieved in 21/67 (31%) females, and
BMI]23 was achieved in 35/69 (50%) males. Fig. 1
shows the distribution of BMI z-score. The correlation
between age and BMI z-score was small, but negative.
R0.09 (p0.08).
The intake of energy, macro- and micronutrients for
136 PI-patients with FR is shown in Table 2. The mean
intake for nearly all calculated nutrients reached the
recommendations of NNR. The mean energy intake was
less than the recommended energy intake of 120% EAR
(pB 0.001), and the target level was only achieved by 51/
136 (38%) PI-patients. Fig. 2 shows the distribution of
energy intake (% EAR).
No significant gender differences were observed for the
variables energy intake (% EAR), FEV1%, FVC% or
BMI z-score (data not shown). Mean BMI was 22.5
Fig. 1. Distribution of BMI z-score in PI-patients with food
record. Mean value0.39.
Table 2. Energy and nutrient intake from 7-day food records in 136 adult PI-patients
Energy and nutrients
a Intake n136 Mean (SD)
Recommended intake Energy
and macronutrients p-values
Energy intake,% EAR 114 (30) 120150
b B0.001
Protein, E% 15.0 (2.3) 1020
c
Fat, E% 33.7 (6.3)  35
b 0.015
PUFA, E% 5.4 (2.2) 510
c
Carbohydrates, E% 49.7 (6.7) 5060
c
sugar, E% 13.3 (6.8) B10
c
Energy intake, kJ/d 12,159 (3,498) 
Protein, g/d 106 (31) 
Fat, g/d 112 (42) 
PUFA, g/d 18.1 (10.4) 
Carbohydrates, g/d 354 (108) 
Recommended intake Fibre
and micronutrients
c
Fibre, g/d 19.6 (7.1) 2535 g/d
Thiamin, mg/d 1.8 (0.6) F(females): 1.1, M(males): 1.4
Riboflavin, mg/d 2.3 (0.9) F: 1.3, M: 1.7
Vitamin C, mg/d 121 (67) F: 75, M: 75
Calcium, mg/d 1,481 (627) F: 800, M: 800
Iron, mg/d 13.4 (5.1) F: 15, M: 9
Magnesium, mg/d 402 (130) F: 280, M: 305
Retinol equivalents, mg/d 1,307 (732) F: 700, M: 900
Vitamin D3, mg/d 5.8 (4.3) F: 7.5, M: 7.5
Tocopherol equivalents, mg /d 11.3 (5.9) F: 8, M: 10
aIntake of energy, macro- and micronutrients is calculated from food intake and oral and enteral energy supplements.
bRecommendations specific for CF (4, 17, 22).
cNordic Nutrition Recommendations 2004 (27).
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females with FR, a difference of 1.0, (95% CI 0.05, 2.0),
p0.004.
There was no correlation between energy intake (%
EAR) and BMI or BMI z-score. The combination of a
normal BMI (]18.5) and an energy intake less than
120% of EAR was found in 73/136 (54%) patients.
Mean E% from fat in PI-patients did not achieve the
recommended level of 35 E% (p0.015) (Table 2). No
differences in E% from fat between men and women were
observed (data not shown).
Patients with pancreatic sufficiency (PS)
Demographic, clinical, and nutritional data were com-
pared between PS- (n38) and PI-patients (n136)
completing the FR. PS-patients were older, 37.3 years
(SD 12.4) (p0.008), and had higher values of FEV1%,
79.6 (SD 20.0) (p0.012) and FVC%, 94.5 (SD 17.3),
p0.029. BMI and BMI z-score did not differ between
the groups.
However, comparing all PS (n78) and all PI-patients
(n345), mean BMI was significantly higher in PS, 23.2
(SD 4.4) versus 21.6 (SD 2.9) in PI-patients, a difference
of 1.6, (95% CI 0.52, 2.6), p0.004. Similarly, BMI z-
score was 0.14(SD 1.3) in PS-versus 0.51(1.1) in PI-
patients, a difference of 0.16, (95% CI 0.052, 0.68), p
0.023.
The mean energy intake (% EAR) was 104 (SD 23) in
PS-patients, and this was significantly lower than 114 (SD
30) in PI-patients, p0.04. The energy percentage from
protein was 14.9 (SD 2.2), from fat 34.4 (SD 6.1), and
from carbohydrates 47.9 (SD 6.2) and did not differ from
PI-patients.
PI-patients with reduced lung function
We further analysed characteristics of PI-patients with
FEV1 B or ]70. BMI was significantly lower in patients
with FEV1 B70% (Table 3). The difference in BMI2.4
(95% CI 1.5, 3.3) is equal to 7.0 kg based on a mean
height of 171 cm in the PI-group (n136). Twelve
patients (18%) were underweight (BMI B18.5) compared
to five patients (7%) with FEV1]70%, p0.06. There
was a linear correlation between BMI and FEV1%
predicted. R0.367. BMI versus FEV1% predicted is
shown in Fig. 3.
There was no significant difference between the groups
regarding the percentage of energy from protein, fat or
carbohydrate (data not shown).
PI-patients with CFRD
The prevalence of CFRD was 17% (60/347). When
comparing all PI-patients with (n60) and without
(n487) diabetes, we found no differences in BMI and
BMI-z-score.
Table 4 shows demographic and clinical data for
patients with and without CFRD completing the FR.
The diabetic PI-patients with FR had lower BMI, a more
negative BMI z-score and a lower FEV1% predicted than
the non-diabetic patients. We observed no significant
difference in energy intake between the diabetic (107%
EAR) and non-diabetic (116% EAR) PI patients. How-
ever, we found some differences in the intake of macro-
nutrients, with higher E% from fat, p0.032, and lower
E% from carbohydrates, p0.019, in diabetic patients
(Table 4).
Fig. 2. Distribution of energy intake as a percentage of EAR
in PI-patients. Mean value114%.
Table 3. Clinical and nutritional data in 135 PI patients with food records, grouped by FEV1% predicted
FEV1B70% n67 Mean (SD) FEV]70% n68 Mean (SD) p-values
Age, years 32.6 (10.3) 30.0 (9.3) 0.13
FEV1, % predicted 47.4 (14.3) 91.1 (14.8) 
FVC, % predicted 70.0 (16.3) 104 (13.0) 
BMI, kg/m
2 20.8 (2.4) 23.2 (3.0) B0.001
BMI z-score 0.88 (1.0) 0.09 (0.9) B0.001
Energy intake, % EAR 113 (30) 114 (30) 0.86
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In this study, the dietary intake and nutritional status in
the adult CF-population of Scandinavia, with emphasis
on PI-patients, were investigated.
The prevalence of underweight was low in Scandinavia
(13%). According to the 2005 CF Foundation Patient
Registry Report, the prevalence of BMI B 18.5 was 22%
in adult CF patients with PI in the USA (20). White et al.
reported the prevalence of BMI B 19.0 to be 26% in 80
adult patients in Leeds who completed a 4-day unweighed
dietary record in 19952000. Mean age was 23.8 (SD 6.4)
years, mean FEV1% was 58.7 (SD 23.9) and mean BMI
20.8 (SD 2.6) (24). The higher prevalence of underweight
in this study may be explained by the severity of lung
disease. The prevalence of BMI]25 was 11% in our
study when all PI-patients (n347) were included. This
was comparable to the results from the UK CF database
2002. They reported the prevalence of BMI  25 to be
10%, although mean FEV1% was lower than in the
Scandinavian population (21). The quality of the dietary
intake seemed satisfactory based on the mean intake of
calculated nutrients (Table 2). Almost all nutrients were
in accordance with recommendations in NNR (27).
Mean values for energy and fat intake are lower than
reported in the studies of White et al., Richardson et al.
and Olveira et al. (2325). Olveira et al. reported the
highest energy intake analysing a 7-day weighed FR from
37 (70% PI) Spanish patients 16 years of age who had
completed puberty. Mean age was 24.5 (SD 9) years,
mean FEV1% 64 (SD 27) and mean BMI 21.8 (SD 4).
BMI wasB18.5 in seven (19%) patients. The energy
intake of the 37 patients was 132% of EAR, and E% from
fat was 39% both for the patients and the 37 controls
(25). Regardless of the high mean energy intake and
including PS-patients in the group, their nutritional status
was not better than in our study. The quite few patients in
the Spanish study may be an explanation for this.
Olveira et al. commented that a high energy, fat-rich
diet is relatively easy to achieve in Spain because this is
part of the ordinary dietary habits in the area. In our
study, E% from fat was at the same level as reported from
national dietary surveys in general population of Scandi-
navia (34).
It is not possible to tell from this Scandinavian cross-
sectional study if the patients were in energy balance with
the reported intake. Energy intakes as low as 50% EAR
cannot represent the energy intake necessary for energy
balance (Fig. 2). The patients who reported the lowest
energy intakes may have underreported their real intake,
or these intakes may be typical for a shorter period of
time.
Collins et al. have reported a lower energy intake in
females than in males (35). We found no significant
Fig. 3. Plot of BMI versus FEV1% predicted in PI-patients
with food record. The equation for the regression line is
BMI19.10.0415FEV1% predicted, indicating that an
increase in FEV1 of 1% is associated with an increase in BMI
of 0.0415.
Table 4. Clinical and nutritional data in 136 PI patients with food records, grouped by diabetes
PI and diabetes n28 Mean (SD) PI without diabetes n108 Mean (SD) p-values
Age, years 31.5 (10) 31.2 (9.8) 0.89
FEV1, % predicted 60.8 (23.6) 71.6 (26.6) 0.04
FVC, % predicted 81.7 (24.5) 88.3 (21.7) 0.20
BMI, kg/m
2 21.0 (2.7) 22.3 (3.0) 0.03
BMI-z-score 0.77 (1.1) 0.29 (1.0) 0.04
Energy intake, % EAR 107 (33) 116 (29) 0.21
Protein, E% 15.4 (2.4) 14.9 (2.3) 0.36
Fat, E% 36.0 (6.8) 33.0 (6.1) 0.03
Carbohydrates, E% 46.8 (7.1) 50.5 (6.4) 0.02
Note: BMI, body mass index; CF, cystic fibrosis; CFRD, CF related diabetes; EAR, estimated average requirement; E%, percent of energy intake; FEV1,
forced expiratory volume in 1 second; FR, food record; FVC, forced vital capacity; NNR, Nordic Nutrition recommendations; PAL, physical activity
level; PI, pancreatic insufficiency; PS, pancreatic sufficiency; PUFA, polyunsaturated fatty acids; REE, resting energy expenditure.
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z-score or FEV1% predicted.
The difference in mean energy intake between PS- and
PI-patients was probably reflecting a real difference in
energy requirement due to normal pancreatic status and
better lung function in PS-patients. It was surprising that
BMI and BMI z-score did not differ between PS- and PI-
patients completing FR. This may be by chance or may
be due to PS-patients being concerned about their weight
were more inclined to food recording.
A lower BMI and a more negative BMI-z-score in the
group with reduced lung function revealed a larger gap
between mean energy intake and energy requirement
compared with the group with nearly normal lung func-
tion. This may be explained with an increase in REE,
although an increase in REE does not always mean an
increase in total energy expenditure (8). It is also possible
that the patientswith moderate or severe lung disease have
been over reporting their intake. Under-reporting of
energy intake is common with dietary self-reporting
methods, but over-reporting of energy intake has been
reported in under weight men (36). In a recent study by
Olveira et al., under-reporting in a 7-day FRwas lower in
CF patients than in controls (37). The authors discuss the
possibility of over reporting due to awareness of nutri-
tional status and energy intake.
The lower BMI and BMI z-score in the diabetic
patients completing FR also revealed a larger gap
between energy requirement and energy intake in the
diabetics compared to non-diabetics. The dietary advices
for CFRD have to take into account the other considera-
tions of CF. Special attention should be given to avoid
unnecessary restriction of carbohydrates and to the
energy intake to prevent or treat weight loss (4, 10).
In the case of weight loss, the European consensus
report recommends a full re-evaluation of all the possible
causes that may affect nutritional status. If nutritional
intervention is indicated, the first step should be max-
imising energy intake using energy-dense foods, then
adding supplements and as a third step enteral nutrition
may be indicated, usually over night (4). Our results
indicate that there is still a potential for better nutritional
follow-up of patients with CF in Scandinavia, especially
when lung function decreases.
The low percentage of FR in two of the centres
(Copenhagen and Uppsala) and no food recording in
the centre in Gothenburg may have impaired the repre-
sentativity of the FR-group for the whole cohort,
although essential clinical data did not differ (Table 1).
Dietary recording is burdensome, and volunteer bias may
be a problem in all studies using dietary recording (32).
In conclusion, the mean energy intake did not achieve
the recommendation in CF. The recommendation of
energy intake in excess of 120% EAR is frequently
referred to in the CF-literature (4, 7, 22) but is based
on quite crude estimates of energy loss and energy
expenditure. The heterogeneity of CF-patients, including
presence of PI, respiratory infection, reduced lung
function, activity and nutritional status, means that
universal recommendations may be difficult to give.
The prevalence of underweight was low in Scandinavia.
Because CF-patients nowadays are doing far better than
previously, the current recommendations for energy
intake may exceed the requirement in a number of CF-
patients.
However, BMI z-score is still negative compared to the
general population data, and nutritional status should be
closely monitored to prevent or treat unintentional
weight loss.
With increased longevity, the potential risks of high
BMI in CF need further investigation and concern.
Nutritional advice and intervention should be individua-
lised and adjusted to actual needs, and be appropriate to
support long-term health.
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